Thrombosis Research
-
Publication Venue For
- Inverse relationship between body mass index and risk of venous thromboembolism among medically ill hospitalized patients: Observations from the APEX trial.. 211:63-69. 2022
- Sonorheometry assessment of platelet function in cardiopulmonary bypass patients: Correlation of blood clot stiffness with platelet integrin αIIbβ3 activity, aspirin usage, and transfusion risk.. 138:96-102. 2016
- Effectiveness of homocysteine lowering vitamins in prevention of thrombotic tendency at high altitude area: A randomized field trial.. 136:758-762. 2015
- Guidelines for treatment and prevention of venous thromboembolism among patients with cancer. 133:S122-S127. 2014
- Biological and pharmacological aspects of perioperative hemorrhagic complications associated with oral platelet-directed antithrombotic agents. Focus on isolated coronary artery bypass grafting and oral irreversible P2Y(12) receptor antagonists.. 123:419-428. 2009
- Association between thrombosis and bloodstream infection in neonates with peripherally inserted catheters.. 122:782-785. 2008
- Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation.. 122:117-123. 2008
- Platelet activation and its patient-specific consequences.. 122:435-441. 2008
- Some things I thought I knew about tissue factor that turn out to be wrong.. 122 Suppl 1:S73-S77. 2008
- Thrombophilia screening in asymptomatic children.. 121:597-604. 2008
- Assessment of clopidogrel responsiveness: measurements of maximum platelet aggregation, final platelet aggregation and their correlation with vasodilator-stimulated phosphoprotein in resistant patients.. 121:107-115. 2007
- Atherothrombosis at a distance: contributing role of existing large-burden vascular disease, circulating biosignals and modulating extravascular tissues.. 119:761-768. 2007
- Clopidogrel resistance?. 120:311-321. 2007
- Delayed thrombin-induced platelet-fibrin clot generation by clopidogrel: a new dose-related effect demonstrated by thrombelastography in patients undergoing coronary artery stenting.. 119:563-570. 2007
- High altitude: a hypercoagulable state: results of a prospective cohort study.. 120:391-397. 2007
- Pro-thrombotic and pro-oxidant effects of diet-induced hyperhomocysteinemia.. 120:117-126. 2007
- Hemostatic activation in a chemically induced rat model of severe hemolysis and thrombosis.. 118:747-753. 2006
- Thrombosis Research: Preface. 117:1-3. 2005
- Clinical implications for patients on antithrombotic therapy while taking supplements.. 117:75-80. 2005
- Dialogue with patient care organizations.. 117:211-222. 2005
- The difference between clopidogrel responsiveness and posttreatment platelet reactivity.. 115:89-94. 2005
- Clopidogrel does not induce fibrinolysis in healthy subjects.. 114:97-100. 2004
- Evaluation of a novel kallikrein inhibitor on hemostatic activation in vitro.. 113:333-339. 2004
- The stratification of platelet reactivity and activation in patients with stable coronary artery disease on aspirin therapy.. 112:9-12. 2003
- Heparin prevents xylum clot signature analyser to detect platelet inhibition with clopidogrel during coronary stenting [2]. 102:95-97. 2001
- Clinical utility of the platelet function analyzer (PFA-100) for the assessment of the platelet status in patients with congestive heart failure (EPCOT trial).. 101:427-433. 2001
- Platelet function and total length of intracoronary stents: is there a correlation?. 101:105-107. 2001
- Initial platelet activity may predict efficacy after chronic oral glycoprotein IIb/IIIa blockade: should we still consider uniform treatment regimens?. 99:105-107. 2000
- The flow cytometer model markedly affects measurement of ex vivo whole blood platelet-bound P-selectin expression in patients with chest pain: are we comparing apples with oranges.. 96:51-56. 1999
- Storing paraformaldehyde-fixed whole blood patient samples after chronic platelet glycoprotein IIb/IIIa blockade: core laboratory considerations.. 95:201-203. 1999
- Moderate hyperhomocyst(e)inemia is associated with the presence of coronary artery disease and the severity of coronary atherosclerosis in Koreans.. 94:45-52. 1999
- Assessment of platelet activity by measuring platelet-derived substances in plasma from patients with acute myocardial infarction: surprising lessons from the GUSTO-III Platelet Study.. 93:149-150. 1999
- S-nitrosoglutathione/glutathione disulphide/Cu2+-dependent stimulation of L-arginine transport in human platelets.. 91:113-120. 1998
- Myths and realities of P-selectin plasma levels in patients with acute myocardial infarction.. 88:343-344. 1997
- Variability in platelet procoagulant activity in healthy volunteers.. 81:533-543. 1996
- An animal model of fibrinolytic bleeding based on the rebleed phenomenon: application to a study of vulnerability of hemostatic plugs of different age.. 67:31-40. 1992
- Effects of 9, 12, 15-octadecatrien-6-ynoic acid on the metabolism of arachidonic acid in platelets and on platelet aggregation.. 65:687-698. 1992
- Recombinant hirudin displaces human factor Xa from its endothelial binding sites.. 57:803-806. 1990
- Lipoprotein(a) inhibition of plasminogen activation by tissue-type plasminogen activator.. 57:155-162. 1990
- Production of chemotactic peptides by neutrophil degradation of heparin cofactor II.. 57:77-85. 1990
- Human mononuclear phagocyte transglutaminase activity cross-links fibrin.. 55:57-68. 1989
- The effect of phosphatidylserine on the inhibition of human factor Xa by the plasma proteinase inhibitors.. 50:901-906. 1988
- The macrophage-mediated regulation of hepatocyte synthesis of antithrombin III and alpha 1-proteinase inhibitor.. 41:707-715. 1986
- Precipitation of fibrinogen, fibrinogen degradation products and fibrin monomer by histone H3.. 39:97-116. 1985
- In vitro effects of acetaminophen and its analogues on human platelet aggregation and thromboxane B2 synthesis.. 38:33-43. 1985
- Inhibitory effect of ristocetin and factor VIII/von Willebrand factor protein on human platelet adenylate cyclase activity.. 30:301-308. 1983
- Lack of thromboxane A2 synthesis in platelet aggregation induced by factor VIII/von Willebrand factor.. 24:245-251. 1981
- The bleeding diathesis in human glycogen storage disease type I: in vitro identification of a naturally occurring inhibitor of ristocetin-induced platelet aggregation.. 18:683-692. 1980
- Effectiveness of intermittent pulsatile elastic stockings for the prevention of calf and thigh vein thrombosis in patients undergoing elective knee surgery.. 16:37-45. 1979
- Streptokinase-induced degradation of crosslinked and uncrosslinked clots.. 13:569-575. 1978
- Catabolism of antithrombin III-protease complexes.. 32:253-254. 1983
- Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trial. 2017
- Binding of anti-GRP78 autoantibodies to cell surface GRP78 promotes cancer progression by activating tissue factor procoagulant activity 2012
- Guidelines for bleeding disorders in women. 2009
- 4B.3 Management of valvular heart disease in pregnancy 2007
- More than menorrhagia: a review of the obstetric and gynaecological manifestations of von Willebrand disease. 2007